Aura Biosciences, Inc.
AURA
$7.65
$0.000.00%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -35.48% | -31.79% | 2.19% | 3.29% | 1.69% |
| Total Depreciation and Amortization | -5.11% | 0.74% | -2.86% | -2.10% | -1.72% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 216.18% | 20.98% | -12.90% | -4.81% | 15.17% |
| Change in Net Operating Assets | 195.31% | -127.34% | -20.63% | -3.16% | 379.20% |
| Cash from Operations | -8.72% | -46.04% | -1.61% | 3.03% | 11.05% |
| Capital Expenditure | 79.41% | 42.05% | -291.11% | -15.38% | 79.14% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -510.93% | 83.33% | 168.22% | -319.69% | -33.28% |
| Cash from Investing | -511.74% | 84.07% | 167.75% | -320.35% | -32.99% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 146,559.32% | -93.60% | -36.58% | -90.62% | 48,357.29% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 17,182.93% | -- | -- | -100.00% | -- |
| Cash from Financing | 80,484.00% | -89.16% | -36.58% | -93.76% | 72,742.71% |
| Foreign Exchange rate Adjustments | -540.74% | 83.13% | -1,042.86% | -255.56% | 142.86% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -167.08% | 111.32% | 120.00% | -186.51% | 958.33% |